Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

GlaxoSmithKline: European Commission Authorizes Nimenix

04/27/2012 | 08:24am US/Eastern

GlaxoSmithKline PLC (>> GlaxoSmithKline plc), the drug company, said Friday that the European Commission has granted marketing authorization for Nimenrix, Meningococcal group A, C, W-135 and Y conjugate vaccine, for active immunization against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W-135 and Y.

-Shares at 1207 GMT, up a penny, or 0.04%, at 1,420.5 pence valuing the company at GBP71.61 billion.

-By Rory Gallivan, Dow Jones Newswires; 44-20-7842-9411; rory.gallivan@dowjones.com

Stocks mentioned in the article : GlaxoSmithKline plc
React to this article
Latest news on GLAXOSMITHKLINE PLC
02/04 GLAXOSMITHKLINE : Jab left boy sleeping 19 hours a day
02/04 GLAXOSMITHKLINE : *hsbc raises glaxosmithkline price target to 1800 pence - 'buy..
02/04 GLAXOSMITHKLINE : *bernstein raises glaxosmithkline price target to 1449 pence -..
02/03 Banks fall to 2011 low to put FTSE 100 under pressure
02/03 GSK dismisses near-term split as new drugs offset falling Advair
02/03DJInvestors' Fears Eased as Glaxo Posts Solid Results -- Update
02/03 GSK refuses to be bounced into early consumer unit spin-off
02/03 GLAXOSMITHKLINE : The state of manufacturing: How to build for the future
02/03 UPDATE : Glaxo To Meet Revenue Target Early As It Reports In-Line 2015
02/03DJInvestors' Fears Eased as Glaxo Posts Solid Results
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials